BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36470752)

  • 21. Higher Risk for Hematological Malignancies in Inflammatory Bowel Disease: A Nationwide Population-based Study in Taiwan.
    Wang LH; Yang YJ; Cheng WC; Wang WM; Lin SH; Shieh CC
    Am J Gastroenterol; 2016 Sep; 111(9):1313-9. PubMed ID: 27296944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of Inflammatory Bowel Disease in Patients With Psoriasis and Psoriatic Arthritis/Ankylosing Spondylitis Initiating Interleukin-17 Inhibitors: A Nationwide Population-Based Study Using the French National Health Data System.
    Penso L; Bergqvist C; Meyer A; Herlemont P; Weill A; Zureik M; Dray-Spira R; Sbidian E
    Arthritis Rheumatol; 2022 Feb; 74(2):244-252. PubMed ID: 34279061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leukemia, lymphoma and multiple myeloma mortality (1950-1999) and incidence (1969-1999) in the Eldorado uranium workers cohort.
    Zablotska LB; Lane RS; Frost SE; Thompson PA
    Environ Res; 2014 Apr; 130():43-50. PubMed ID: 24583244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased Risk of Inflammatory Bowel Disease Among Patients With Ankylosing Spondylitis: A 13-Year Population-Based Cohort Study.
    Wang S; Tsou HK; Chiou JY; Wang YH; Zhang Z; Wei JC
    Front Immunol; 2020; 11():578732. PubMed ID: 33123163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century.
    Pulte D; Jansen L; Brenner H
    Blood Cancer J; 2020 May; 10(5):56. PubMed ID: 32404891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Family history of hematopoietic malignancy and risk of lymphoma.
    Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
    J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
    Pulte D; Gondos A; Brenner H
    J Natl Cancer Inst; 2008 Sep; 100(18):1301-9. PubMed ID: 18780868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
    Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD
    Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology and Predictors of 30-Day Readmission in CAR-T Cell Therapy Recipients.
    Sharma A; Singh V; Deol A
    Transplant Cell Ther; 2023 Feb; 29(2):108.e1-108.e7. PubMed ID: 36371048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of Hematologic Malignancies in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study.
    Tietsche de Moraes Hungria V; Chiattone C; Pavlovsky M; Abenoza LM; Agreda GP; Armenta J; Arrais C; Avendaño Flores O; Barroso F; Basquiera AL; Cao C; Cugliari MS; Enrico A; Foggliatto LM; Galvez KM; Gomez D; Gomez A; de Iracema D; Farias D; Lopez L; Mantilla WA; Martínez D; Mela MJ; Miguel CE; Ovilla R; Palmer L; Pavlovsky C; Ramos C; Remaggi G; Santucci R; Schusterschitz S; Sossa CL; Tuna-Aguilar E; Vela J; Santos T; de la Mora O; Machnicki G; Fernandez M; Barreyro P
    J Glob Oncol; 2019 Nov; 5():1-19. PubMed ID: 31774711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in hematological cancer in the elderly in Denmark, 1980-2012.
    Ocias LF; Larsen TS; Vestergaard H; Friis LS; Abildgaard N; Frederiksen H;
    Acta Oncol; 2016; 55 Suppl 1():98-107. PubMed ID: 26783877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of the incidence and trends of hematologic malignancies between Japan and the United States].
    Chihara D; Ito H; Matsuo K
    Rinsho Ketsueki; 2015 Apr; 56(4):366-74. PubMed ID: 25971266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis.
    Klingberg E; Strid H; Ståhl A; Deminger A; Carlsten H; Öhman L; Forsblad-d'Elia H
    Arthritis Res Ther; 2017 Feb; 19(1):21. PubMed ID: 28148281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of hematological malignancy in blood donors: A nationwide cohort study.
    Zhao J; Dahlén T; Brynolf A; Edgren G
    Transfusion; 2020 Nov; 60(11):2591-2596. PubMed ID: 32818321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The Risk and Survival Analysis of Multiple Malignancies in Hematologic Malignancy Patients: A Single Chinese Center Retrospective Study, 2009 through 2017].
    Zhang XC; Fan L; Lu H; Qian SX; Chen LJ; Xu W; Li JY; Qu XY; Zhao XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):389-395. PubMed ID: 37096510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-world incidence of inflammatory bowel disease among patients with other chronic inflammatory diseases treated with interleukin-17a or phosphodiesterase 4 inhibitors.
    Emond B; Ellis LA; Chakravarty SD; Ladouceur M; Lefebvre P
    Curr Med Res Opin; 2019 Oct; 35(10):1751-1759. PubMed ID: 31106607
    [No Abstract]   [Full Text] [Related]  

  • 37. The epidemiology of extra-articular manifestations in ankylosing spondylitis: a population-based matched cohort study.
    Stolwijk C; Essers I; van Tubergen A; Boonen A; Bazelier MT; De Bruin ML; de Vries F
    Ann Rheum Dis; 2015 Jul; 74(7):1373-8. PubMed ID: 24658834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries: the National Cancer Institute Cohort.
    Beane Freeman LE; Blair A; Lubin JH; Stewart PA; Hayes RB; Hoover RN; Hauptmann M
    J Natl Cancer Inst; 2009 May; 101(10):751-61. PubMed ID: 19436030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies.
    Castillo JJ; Mull N; Reagan JL; Nemr S; Mitri J
    Blood; 2012 May; 119(21):4845-50. PubMed ID: 22496152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
    Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
    Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.